Lessee, Operating Lease, Liability, to be Paid, Year Two of ACRO BIOMEDICAL CO., LTD. from 31 Dec 2023 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
ACRO BIOMEDICAL CO., LTD. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 31 Dec 2023 to 30 Sep 2024.
  • ACRO BIOMEDICAL CO., LTD. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 30 Sep 2024 was $27,780.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)

ACRO BIOMEDICAL CO., LTD. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $27,780 30 Sep 2024 10-Q 23 Jul 2025 2024 Q3
Q2 2024 $27,780 30 Jun 2024 10-Q 23 Jul 2025 2024 Q2
Q1 2024 $27,780 31 Mar 2024 10-Q 22 Jul 2025 2024 Q1
Q4 2023 $27,780 31 Dec 2023 10-K 18 Jul 2025 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.